What is Myriad Genetics's total equity?

Myriad Genetics (MYGN) reported total equity of $337.4M in Q1 2026.

How has Myriad Genetics's total equity changed year-over-year?

Myriad Genetics's total equity decreased by 52.1% year-over-year, from $704.9M to $337.4M.

What is the long-term trend for Myriad Genetics's total equity?

Over 5 years (2020 to 2025), Myriad Genetics's total equity has grown at a -16.0% compound annual growth rate (CAGR), from $881M to $368M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Myriad Genetics MYGN Total Equity

Total Equity at other companies

Labcorp HoldingsLH

$8.73B+5.1%

Quest DiagnosticsDGX

$7.37B+6.3%

NeoGenomicsNEO

$828.76M-6.7%

VeracyteVCYT

$1.34B+12.5%

Guardant HealthGH

-$181.07M+27.8%

Natera, Inc.NTRA

$1.77B+43.1%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's total equity?: Myriad Genetics (MYGN) reported total equity of $337.4M in Q1 2026.
How has Myriad Genetics's total equity changed year-over-year?: Myriad Genetics's total equity decreased by 52.1% year-over-year, from $704.9M to $337.4M.
What is the long-term trend for Myriad Genetics's total equity?: Over 5 years (2020 to 2025), Myriad Genetics's total equity has grown at a -16.0% compound annual growth rate (CAGR), from $881M to $368M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.